These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2373030)

  • 1. [Treatment of persistent corneal epithelial disorders with human plasma fibronectin eyedrops].
    Qu XA
    Zhonghua Yan Ke Za Zhi; 1990 Jan; 26(1):21-3. PubMed ID: 2373030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of fibronectin eyedrops on epithelial disorders after herpetic keratitis.
    Nishida T; Nakagawa S; Manabe R
    Ophthalmology; 1985 Feb; 92(2):213-6. PubMed ID: 3982800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical fibronectin therapy of persistent corneal epithelial defects. Fibronectin Study Group.
    McCulley JP; Horowitz B; Husseini ZM; Horowitz M
    Trans Am Ophthalmol Soc; 1993; 91():367-86; discussion 386-90. PubMed ID: 8140699
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical efficacy of topical homologous fibronectin in persistent corneal epithelial disorders.
    Kim KS; Oh JS; Kim IS; Jo JS
    Korean J Ophthalmol; 1992 Jun; 6(1):12-8. PubMed ID: 1434041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The cornea: stasis and dynamics].
    Nishida T
    Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):179-212; discussion 213. PubMed ID: 18411711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid preparation of purified autologous fibronectin eyedrops from patient's plasma.
    Nishida T; Nakagawa S; Awata T; Nishibayashi C; Manabe R
    Jpn J Ophthalmol; 1982; 26(4):416-24. PubMed ID: 7166901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical fibronectin in the treatment of persistent corneal epithelial defects and trophic ulcers.
    Phan TM; Foster CS; Boruchoff SA; Zagachin LM; Colvin RB
    Am J Ophthalmol; 1987 Nov; 104(5):494-501. PubMed ID: 3674183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical fibronectin treatment in persistent corneal epithelial defects and corneal ulcers.
    Kim KS; Oh JS; Kim IS; Jo JS
    Korean J Ophthalmol; 1990 Jun; 4(1):5-11. PubMed ID: 2214253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent epithelial defect following penetrating keratoplasty: an adverse effect of diclofenac eyedrops.
    Shimazaki J; Saito H; Yang HY; Toda I; Fujishima H; Tsubota K
    Cornea; 1995 Nov; 14(6):623-7. PubMed ID: 8575187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy.
    Yamada N; Matsuda R; Morishige N; Yanai R; Chikama TI; Nishida T; Ishimitsu T; Kamiya A
    Br J Ophthalmol; 2008 Jul; 92(7):896-900. PubMed ID: 18511539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open clinical study of eye drops containing the fibronectin-derived peptide PHSRN for treatment of persistent corneal epithelial defects.
    Yamada N; Morishige N; Yanai R; Morita Y; Kimura K; Chikama T; Nomizu M; Sonoda KH; Nishida T
    Cornea; 2012 Dec; 31(12):1408-13. PubMed ID: 23135532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical fibronectin ophthalmic solution in the treatment of persistent defects of the corneal epithelium. Chiron Vision Fibronectin Study Group.
    Gordon JF; Johnson P; Musch DC
    Am J Ophthalmol; 1995 Mar; 119(3):281-7. PubMed ID: 7872387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and histological findings on the effect of fibronectin in rabbits with experimental corneal disorders.
    Hiraki S; Hayami H; Numata K; Kubota Y; Kobayashi M; Tanaka S; Karges HE
    Arzneimittelforschung; 1990 Dec; 40(12):1336-40. PubMed ID: 1710125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous persistent epithelial defects after cataract surgery.
    Nishida T; Yagi J; Fukuda M; Kusube T; Otori T
    Cornea; 1987; 6(1):32-7. PubMed ID: 3581842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of homologous fibronectin to persistent human corneal epithelial defects.
    Spigelman AV; Deutsch TA; Sugar J
    Cornea; 1987; 6(2):128-30. PubMed ID: 3608513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibronectin in alkali burns of the rabbit cornea.
    Spigelman AV; Vernot JA; Deutsch TA; Peyman GA; Molnar J
    Cornea; 1985-1986; 4(3):169-72. PubMed ID: 3843316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defects.
    López-Plandolit S; Morales MC; Freire V; Etxebarría J; Durán JA
    Cornea; 2010 Aug; 29(8):843-8. PubMed ID: 20508516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis.
    Yoon KC; You IC; Im SK; Jeong TS; Park YG; Choi J
    Ophthalmology; 2007 Sep; 114(9):1637-42. PubMed ID: 17382396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous serum eyedrops in the treatment of aniridic keratopathy.
    López-García JS; Rivas L; García-Lozano I; Murube J
    Ophthalmology; 2008 Feb; 115(2):262-7. PubMed ID: 17675158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of umbilical cord serum eyedrops for recurrent corneal erosions.
    Yoon KC; Choi W; You IC; Choi J
    Cornea; 2011 Jul; 30(7):744-8. PubMed ID: 21436685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.